Advanced Oxygen Technologies INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Advanced Oxygen Technologies reports modest revenue growth and net income for the nine months ending March 31, 2026, with primary operations in Danish real estate leasing.
OTC.Pink
Advanced Oxygen Technologies, Inc. reported a net loss for the six months ended December 31, 2025, alongside a significant working capital deficit and ongoing efforts to secure financing and pursue acquisitions.
OTC.Pink
Advanced Oxygen Technologies, Inc. reported a reduced net loss of $3,445 for the quarter ended September 30, 2025, driven by increased rental revenue and lower operating expenses, despite a significant working capital deficit and ineffective disclosure controls.
OTC.Pink
Advanced Oxygen Technologies, Inc. reports a marginal increase in net income for the quarter ended March 31, 2025, driven primarily by lease revenues.
OTC.Pink
Advanced Oxygen Technologies, Inc. reports increased revenues and net income for the three and six months ended December 31, 2024, primarily driven by lease revenues.
OTC.Pink
Advanced Oxygen Technologies, Inc. reports a slight revenue increase for the quarter ended September 30, 2024, while actively pursuing acquisitions and addressing internal control weaknesses.
OTC.Pink
Advanced Oxygen Technologies, Inc. reports a modest increase in net income for the quarter ended March 31, 2024, while actively pursuing potential acquisitions to enhance growth.
OTC.Pink
Advanced Oxygen Technologies, Inc. reports a net income of $328 for the six months ended December 31, 2023, driven by lease revenues and currency fluctuations, while actively pursuing acquisition opportunities.